| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 13 Nov 25 | SUPN Supernus Pharmaceuticals | Performance Share Unit Common Stock | Grant | Acquire A | No | No | 0 | 1,500 | 0.00 | 1,500 |
| 25 Aug 25 | SUPN Supernus Pharmaceuticals | Common Stock | Payment of exercise | Dispose F | No | No | 41.46 | 581 | 24.09 k | 13,718 |
| 25 Aug 25 | SUPN Supernus Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 0 | 1,250 | 0.00 | 14,299 |
| 25 Aug 25 | SUPN Supernus Pharmaceuticals | Performance Share Unit Common Stock | Option exercise | Dispose M | No | No | 0 | 1,250 | 0.00 | 0 |
| 7 Aug 25 | SUPN Supernus Pharmaceuticals | Performance Share Unit Common Stock | Grant | Acquire A | No | No | 0 | 1,250 | 0.00 | 1,250 |
| 5 Mar 25 | SUPN Supernus Pharmaceuticals | Common Stock | Payment of exercise | Dispose F | No | No | 33.05 | 575 | 19.00 k | 12,704 |
| 5 Mar 25 | SUPN Supernus Pharmaceuticals | Common Stock | Payment of exercise | Dispose F | No | No | 33.05 | 575 | 19.00 k | 13,279 |
| 5 Mar 25 | SUPN Supernus Pharmaceuticals | Common Stock | Payment of exercise | Dispose F | No | No | 33.05 | 335 | 11.07 k | 13,854 |
| 23 Feb 25 | SUPN Supernus Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 1,250 | 0.00 | 14,189 |
| 23 Feb 25 | SUPN Supernus Pharmaceuticals | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 1,250 | 0.00 | 2,500 |